CVS Health will divide into two separate companies, separating its retail pharmacy business from its insurance and pharmacy-benefit operations. One company will keep the CVS Health name and be led by CEO David Joyner. This move reverses CVS's previous strategy of integrating healthcare services, including its $78 billion acquisition of Aetna in 2018. The split responds to growing regulatory scrutiny of pharmacy benefit managers and aims to streamline operations amid challenges. CVS reported record revenue of $402.1 billion in 2025 and its shares rose 1.2% in after-hours trading following the news.
Following CVS Health's announcement to split its pharmacy and insurance businesses, the stock showed a notable rise. On Pluang, CVS shares are priced at USD 92.20, up 4.17% as of Nov 04, 2026 07:21 WIB. The company holds a market cap of $113.20 billion and offers a 3.01% dividend yield, with most Pluang investors buying rather than selling the stock.
